je.st
news
Home › sangamo
Tag: sangamo
Sangamo Announces FDA Clearance Of Investigational New Drug Application
2016-02-09 03:38:16| drugdiscoveryonline News Articles
Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application for SB-318, a single treatment strategy intended to provide a life-long therapy for Mucopolysaccharidosis Type I (MPS I).
Tags: application
drug
clearance
announces
Sangamo to buy San Diego's Ceregene
2013-08-27 09:11:16| Biotech - Topix.net
Sangamo BioSciences Inc. will buy Ceregene Inc., a privately held company working on a virus-delivered gene therapy for Alzheimer's disease, in a stock and cash deal.
Sites : [1]